Helmy Siragy
Division of Endocrinology and Metabolism, University of Virginia Health Sciences Center, Charlottesville, VA, USA F1000 Faculty Member (since 02 November 2006)BIOGRAPHY
ACADEMIC POSITION:Helmy M Siragy, MD, FACP, FAHA is Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Virginia Health System in Charlottesville, Virginia.
EDUCATION AND TRAINING:
He obtained his residency training at the University of Texas Medical Branch in Galveston, TX, followed by fellowships in Endocrinology and Hypertension under the supervision of Professor Frederic C Bartter at the University of Texas Health Sciences Center in San Antonio. He is board certified in internal medicine, with subspecialty in endocrinology, diabetes and metabolism and certified as Hypertension Specialist by the American Society of Hypertension.
MEMBERSHIPS:
He is a fellow of the American College of Physician, the American Heart Association and is a member of numerous national and international Endocrine and Hypertension Societies. He is a member of and reviewer for multiple national and international committees including the American Heart Association and the United States National Institutes of Health. He is a member of the editorial boards of several hypertension, Endocrine, vascular biology and Kidney journals and currently the Section Editor for the Antihypertensive Agents: Mechanisms of Drug Action section, Current Hypertension Reports Journal and Current Hypertension Reviews Journal.
RESEARCH INTERSTS:
An international expert on subjects related to hypertension, Dr Siragy was first to discover and publish that stimulation of angiotensin AT2 receptor leads to generation of nitric oxide. Dr Siragy has authored more than 250 medical journal articles and abstracts, and twenty one medical textbook chapters, including the chapter on the kidney and the renin angiotensin system in Braunwald Atlas of Heart Diseases, Angiotensin and Diabetic Nephropathy in Harrison's online textbook of Medicine and The Angiotensin Receptor: AT1 and AT2 in Hypertension - A Companion to Brenner and Rectors The Kidney. Dr Siragy's primary research interests are in the areas of the renin-angiotensin system, cardiac ischemia, diabetic nephropathy and (Pro)Renin receptor.
HOME PAGE
http://www.medicine.virginia.edu/clinical/departments/medicine/divisions/endocrine/labs/siragy-lab/about-the-lab
RECOMMENDATIONS
Viewing Article Recommendations by Faculty Members requires a subscription.
If you believe you should be able to view this content, contact us at info@f1000.com.
Helmy Siragy has been added to your "Faculty I'm Following" page in MyF1000
Follow/Unfollow any Faculty via their recommendations, biography pages, or MyF1000

